ENE — Centrum Medyczne Enel Med SA Balance Sheet
0.000.00%
- PLN523.19m
- PLN771.43m
- PLN735.59m
- 67
- 46
- 46
- 51
Annual balance sheet for Centrum Medyczne Enel Med SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 19.1 | 77.8 | 26.5 | 37.2 | 38.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 20.2 | 21.1 | 25.4 | 30.4 | 33.5 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 46.4 | 105 | 59.7 | 79.4 | 86 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 333 | 311 | 341 | 363 | 419 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 393 | 438 | 432 | 476 | 537 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 87.2 | 94.2 | 104 | 136 | 131 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 294 | 262 | 280 | 316 | 364 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 98.9 | 176 | 152 | 160 | 173 |
| Total Liabilities & Shareholders' Equity | 393 | 438 | 432 | 476 | 537 |
| Total Common Shares Outstanding |